N/A
Manufactured by Pfizer Laboratories Div Pfizer Inc
18,857 FDA adverse event reports analyzed
Last updated: 2026-04-14
MISOPROSTOL is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Pfizer Laboratories Div Pfizer Inc. The most commonly reported adverse reactions for MISOPROSTOL include HAEMORRHAGE, ABORTION INCOMPLETE, OFF LABEL USE, FOETAL EXPOSURE DURING PREGNANCY, PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for MISOPROSTOL.
Out of 9,541 classified reports for MISOPROSTOL:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 18,857 FDA FAERS reports that mention MISOPROSTOL. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include HAEMORRHAGE, ABORTION INCOMPLETE, OFF LABEL USE, FOETAL EXPOSURE DURING PREGNANCY, PAIN, ANAEMIA. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Pfizer Laboratories Div Pfizer Inc in connection with MISOPROSTOL. Always verify the specific product and NDC with your pharmacist.